Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
52.78
+0.02 (0.04%)
Apr 29, 2026, 12:46 PM EDT - Market open
Soleno Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,730 | 2,487 | 1,938 | 1,228 | 16 | 33 | |
| Market Cap Growth | -11.46% | 28.31% | 57.88% | 7498.61% | -50.63% | -78.71% | |
| Enterprise Value | 2,277 | 1,983 | 1,656 | 1,176 | -3 | 5 | |
| Last Close Price | 52.76 | 46.30 | 44.95 | 40.25 | 1.98 | 6.15 | |
| PE Ratio | 135.28 | 121.45 | - | - | - | - | |
| Forward PE | 13.36 | 13.68 | - | - | - | - | |
| PS Ratio | 14.34 | 13.06 | - | - | - | - | |
| PB Ratio | 6.13 | 5.53 | 7.91 | 7.79 | 1.56 | 1.84 | |
| P/TBV Ratio | 6.13 | 5.59 | 8.13 | 8.25 | - | 6.35 | |
| P/FCF Ratio | 58.44 | 53.22 | - | - | - | - | |
| P/OCF Ratio | 58.35 | 53.14 | - | - | - | - | |
| EV/Sales Ratio | 11.96 | 10.42 | - | - | - | - | |
| EV/EBITDA Ratio | 134.21 | 116.90 | - | - | - | - | |
| EV/EBIT Ratio | 152.32 | 132.67 | - | - | - | - | |
| EV/FCF Ratio | 48.74 | 42.45 | - | - | - | - | |
| Debt / Equity Ratio | 0.12 | 0.12 | 0.22 | 0.00 | 0.02 | 0.03 | |
| Debt / EBITDA Ratio | 2.93 | 2.93 | - | - | - | - | |
| Debt / FCF Ratio | 1.13 | 1.13 | - | - | - | - | |
| Net Debt / Equity Ratio | -1.01 | -1.01 | -1.08 | -1.07 | -1.40 | -1.17 | |
| Net Debt / EBITDA Ratio | -26.73 | -26.73 | 1.46 | 4.61 | 0.62 | 0.69 | |
| Net Debt / FCF Ratio | -9.71 | -9.71 | 3.84 | 6.79 | 0.70 | 0.75 | |
| Asset Turnover | 0.43 | 0.43 | - | - | - | - | |
| Quick Ratio | 5.44 | 5.44 | 15.55 | 14.75 | 2.00 | 2.66 | |
| Current Ratio | 5.80 | 5.80 | 15.68 | 14.89 | 2.14 | 2.80 | |
| Return on Equity (ROE) | 6.01% | 6.01% | -87.35% | -46.45% | -171.05% | -97.60% | |
| Return on Assets (ROA) | 2.09% | 2.09% | -45.06% | -23.33% | -50.58% | -40.11% | |
| Return on Capital Employed (ROCE) | 3.00% | 3.00% | -59.10% | -22.90% | -130.90% | -117.10% | |
| Earnings Yield | 0.75% | 0.84% | -9.07% | -3.18% | -148.97% | -94.47% | |
| FCF Yield | 1.71% | 1.88% | -3.58% | -2.03% | -128.71% | -84.94% | |
| Buyback Yield / Dilution | -30.39% | -30.39% | -143.61% | -96.40% | -57.90% | -27.39% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.